The RAINIER Study (NCT06496607) is an ongoing Phase IIa clinical trial investigating Solrikitug for adults with asthma. This randomized, double-blind, placebo-controlled study evaluates three dose ...

Vinay Prasad, a hematologist-oncologist known for his vocal opposition to elements of the Covid response, also jumped on Cavazzoni’s move back to Pfizer in a same-day blog post titled “FDA approves ...

Trump said overnight that the US would soon introduce a 'major tariff' on pharmaceuticals to force firms to relocate medicine ...

KEY TAKEAWAYS The Dow and S&P 500 wavered between gains and losses at midday Wednesday amid heightened volatility after the U ...

Shares of several major pharmaceutical companies slumped Wednesday morning as President Donald Trump threatened tariffs on ...

German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact ...

ADGHW to accelerate collaboration, responsible innovation, and investment among researchers, policy makers, healthcare ...

The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.

The pharma sector was spared from Trump's sweeping tariff plan last week, which kicked in on Wednesday, but the U.S. president had previously pledged to impose tariff on pharma products and his ...

Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately. Vlad Coric is the Chairman and Chief Executive Officer ...

GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District ...

U.S. Trade Representative Jamieson Greer said the Trump Administration excluded pharmaceuticals and semiconductors from reciprocal tariffs ...